Zevia PBC (ZVIA) 10-Q 8 May 24 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	May 01, 2024
Document Information [Line Items]
Document Type	10-Q
Entity Registrant Name	Zevia PBC
Amendment Flag	false
Entity Central Index Key	0001854139
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Incorporation, State or Country Code	DE
Securities Act File Number	001-40630
Entity Tax Identification Number	86-2862492
Entity Address, Address Line One	15821 Ventura Blvd.
Entity Address, Address Line Two	Suite 135
Entity Address, City or Town	Encino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91436
City Area Code	424
Local Phone Number	343-2654
Title of 12(b) Security	Class A common stock, par value $0.001 pershare
Trading Symbol	ZVIA
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Small Business	true
Entity Shell Company	false
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		58,180,510
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		14,117,351

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 28,720	$ 31,955
Accounts receivable, net	14,048	11,119
Inventories	30,621	34,550
Prepaid expenses and other current assets	3,965	5,063
Total current assets	77,354	82,687
Property and equipment, net	1,902	2,109
Right-of-use assets under operating leases, net	1,812	1,959
Intangible assets, net	3,435	3,523
Other non-current assets	560	579
Total assets	85,063	90,857
Current liabilities:
Accounts payable	19,045	21,169
Accrued expenses and other current liabilities	8,153	5,973
Current portion of operating lease liabilities	592	575
Total current liabilities	27,790	27,717
Operating lease liabilities, net of current portion	1,216	1,373
Total liabilities	29,006	29,090
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred Stock, $0.001 par value. 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023	0	0
Class A common stock, $0.001 par value. 550,000,000 shares authorized, 58,135,308 and 54,220,017 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.	58	54
Class B common stock, $0.001 par value. 250,000,000 shares authorized, 14,117,351 and 17,283,177 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.	14	17
Additional paid-in capital	187,366	191,144
Accumulated deficit	(107,161)	(101,337)
Total Zevia PBC stockholder's equity	80,277	89,878
Noncontrolling Interests	(24,220)	(28,111)
Total equity	56,057	61,767
Total liabilities and equity	$ 85,063	$ 90,857

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Class A [Member]
Common stock par value	$ 0.001	$ 0.001
Common stock shares authorized	550,000,000	550,000,000
Common stock shares issued	58,135,308	54,220,017
Common stock shares outstanding	58,135,308	54,220,017
Common Class B [Member]
Common stock par value	$ 0.001	$ 0.001
Common stock shares authorized	250,000,000	250,000,000
Common stock shares issued	14,117,351	17,283,177
Common stock shares outstanding	14,117,351	17,283,177

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024		Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net sales	$ 38,799		$ 43,300
Cost of goods sold	21,080		23,195
Gross profit	17,719		20,105
Operating expenses:
Selling and marketing	15,070		11,912
General and administrative	8,115		8,645
Equity-based compensation	1,489		2,380
Depreciation and amortization	328		419
Total operating expenses	25,002		23,356
Loss from operations	(7,283)		(3,251)
Other income, net	97		340
Loss before income taxes	(7,186)		(2,911)
Provision for income taxes	13		1
Net loss and comprehensive loss	(7,199)		(2,912)
Loss attributable to noncontrolling interest	1,375		821
Net loss attributable to Zevia PBC	$ (5,824)		$ (2,091)
Net loss per share attributable to common stockholders, basic	$ (0.1)		$ (0.03)
Net loss per share attributable to common shareholders, diluted	$ (0.1)		$ (0.04)
Weighted average common units outstanding, basic	55,890,168		49,372,874
Weighted average common units outstanding, diluted	55,890,168	[1]	72,250,338
[1] (3) There was no assumed conversion for Class B nor diluted effect of options and RSUs for the three months ended March 31, 2024 as they were anti-dilutive.

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Thousands	Total	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]	Common Stock [Member] Common Class A [Member]	Common Stock [Member] Common Class B [Member]
Beginning Balance (in shares) at Dec. 31, 2022					47,774,046	21,798,600
Beginning Balance at Dec. 31, 2022	$ 81,786	$ 189,724	$ (79,843)	$ (28,165)	$ 48	$ 22
Vesting and release of common stock under equity incentive plans, net (in shares)					981,902
Vesting and release of common stock under equity incentive plans, net		(1)			$ 1
Exchange of Class B common stock for Class A common stock (in shares)					537,991	(537,991)
Exchange of Class B common stock for Class A common stock		(724)		724	$ 1	$ (1)
Exercise of stock options	23	23
Exercise of stock options Shares					30,424
Equity-based compensation	2,380	2,380
Net loss	(2,912)		(2,091)	(821)
Ending Balance at Mar. 31, 2023	81,277	191,402	(81,934)	(28,262)	$ 50	$ 21
Ending Balance (in shares) at Mar. 31, 2023					49,324,363	21,260,609
Beginning Balance (in shares) at Dec. 31, 2023					54,220,017	17,283,177
Beginning Balance at Dec. 31, 2023	$ 61,767	191,144	(101,337)	(28,111)	$ 54	$ 17
Vesting and release of common stock under equity incentive plans, net (in shares)					743,465
Vesting and release of common stock under equity incentive plans, net		(1)			$ 1
Exchange of Class B common stock for Class A common stock (in shares)					3,165,826	(3,165,826)
Exchange of Class B common stock for Class A common stock		(5,266)		5,266	$ 3	$ (3)
Exercise of stock options Shares	6,000				6,000
Equity-based compensation	$ 1,489	1,489
Net loss	(7,199)		(5,824)	(1,375)
Ending Balance at Mar. 31, 2024	$ 56,057	$ 187,366	$ (107,161)	$ (24,220)	$ 58	$ 14
Ending Balance (in shares) at Mar. 31, 2024					58,135,308	14,117,351

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net loss	$ (7,199)	$ (2,912)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Non-cash lease expense	147	142
Depreciation and amortization	328	419
Gain on disposal of property, equipment and software, net	(12)	0
Amortization of debt issuance cost	19	19
Equity-based compensation	1,489	2,380
Changes in operating assets and liabilities:
Accounts receivable, net	(2,929)	(3,239)
Inventories	3,929	(1,374)
Prepaid expenses and other assets	1,098	546
Accounts payable	(2,112)	14,589
Accrued expenses and other current liabilities	2,180	(1,025)
Operating lease liabilities	(140)	(148)
Net cash (used in) provided by operating activities	(3,202)	9,397
Investing activities:
Purchases of property, equipment and software	(33)	(862)
Net cash used in investing activities	(33)	(862)
Financing activities:
Proceeds from revolving line of credit	8,000	0
Repayment of revolving line of credit	(8,000)	0
Proceeds from exercise of stock options	0	23
Net cash provided by financing activities	0	23
Net change from operating, investing, and financing activities	(3,235)	8,558
Cash and cash equivalents at beginning of period	31,955	47,399
Cash and cash equivalents at end of period	28,720	55,957
Non-cash investing and financing activities
Capital expenditures included in accounts payable	0	71
Conversion of Class B common stock to Class A common stock	5,266	724
Operating lease right-of-use assets obtained in exchange for lease liabilities	0	1,818
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	26	19
Cash paid for income taxes	$ 20	$ 52

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Description of Business

Description of Business	3 Months Ended
	Mar. 31, 2024
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Description of Business	1. DESCRIPTION OF BUSINESS Organization and operations Zevia PBC (the “Company,” “we,” “us,” “our”), is a growth beverage company that develops, markets, sells, and distributes great tasting, zero sugar beverages made with simple, plant-based ingredients. We are a Delaware public benefit corporation and have been designated as a “Certified B Corporation,” and are focused on addressing the global health challenges resulting from excess sugar consumption by offering a broad portfolio of zero sugar, zero calorie, naturally sweetened beverages. All Zevia® beverages are Non-GMO Project verified, gluten-free, Kosher, vegan and zero sodium and include a variety of flavors across Soda, Energy Drinks, Organic Tea, and Kids drinks. Our products are distributed and sold principally across the United States (“U.S.”) and Canada through a diverse network of major retailers in the food, drug, warehouse club, mass, natural and e-commerce channels and in grocery and natural product stores and specialty outlets. The Company’s products are manufactured and maintained at third-party beverage production and warehousing facilities located in both the U.S. and Canada. The Company completed its initial public offering (“IPO”) of 10,700,000 shares of its Class A common stock at an offering price of $ 14.00 per share on July 26, 2021. Its Class A common stock is listed on the New York Stock Exchange trading under the ticker symbol “ZVIA.” In connection with the IPO, the Company also completed certain reorganization transactions (the “Reorganization Transactions”), pursuant to which Zevia LLC became the predecessor of the Company for financial reporting purposes. The Company is a holding company, and its sole material asset is its controlling equity interest in Zevia LLC. As the sole managing member of Zevia LLC, the Company operates and controls all of the business and affairs of Zevia LLC.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these financial statements do not include all information and footnotes required by U.S. GAAP for complete financial statements and are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024, or for any other interim period or any other future fiscal year. The condensed consolidated balance sheet as of December 31, 2023 included herein was derived from the audited financial statements as of that date but does not include all disclosures, including certain notes, required by U.S. GAAP that are required on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. Therefore, these interim financial statements should be read in conjunction with the financial statements for the fiscal year ended December 31, 2023 and accompanying notes included in the Annual Report. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for the fair presentation of the condensed consolidated financial statements for the periods presented have been reflected. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiary, Zevia LLC, that it controls due to ownership of a majority equity interest. All intercompany transactions and balances have been eliminated in consolidation. The Company owns a majority economic interest in, and operates and controls all of the businesses and affairs of, Zevia LLC. Accordingly, the Company has prepared these accompanying unaudited condensed consolidated financial statements in accordance with Accounting Standards Codification (“ASC”) Topic 810, Consolidation . On January 1, 2022, the Company and Zevia LLC entered into a service agreement to transfer the services of all employees of the Company to Zevia LLC. Under terms of the service agreement between the entities, the payroll costs of employees are borne by Zevia LLC while certain other non-payroll costs, such as those associated with stock compensation arrangements, remain with the Company. In addition, pursuant to the Thirteenth Amended and Restated Limited Liability Company Agreement of Zevia LLC, dated as of July 21, 2021, Zevia LLC shall reimburse the Company for certain expenses for overhead, administrative, and other expenses, at the Company’s discretion. For the three months ended March 31, 2024 and 2023 , it was determined that the majority of such costs will be retained by the Company, with certain costs directly attributable to Zevia LLC being borne by that entity. These costs impacted the amount of net loss reported by Zevia LLC and consequently impacted the amount allocated to noncontrolling interest. Use of estimates The preparation of the accompanying unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the reported amount of net sales and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by the Company relate to: net sales and associated cost recognition; the useful lives assigned to and the recoverability of property and equipment; adjustments recorded for inventory obsolescence and adjustments made for net realizable value; the incremental borrowing rate for lease liabilities; allowance for doubtful accounts; the useful lives assigned to and the recoverability of intangible assets; realization of deferred tax assets; and the determination of the fair value of equity instruments, including restricted unit awards, and equity-based compensation awards. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of its assets and liabilities. Recent accounting pronouncements The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the accompanying unaudited condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. Recently Issued Accounting Pronouncements – Not Yet Adopted In November 2023, the FASB issues ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . This ASU requires entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance. In December 2023, the FASB issued ASU No. 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures . The guidance requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The guidance is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The ASU is effective for private companies for annual periods beginning after December 15, 2025, with early adoption permitted. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. The Company is currently evaluating the impact of adopting this guidance. Any other recently issued accounting pronouncements are neither relevant, nor expected to have a material impact on the Company’s financial statements.

Revenues

Revenues	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenues	3. REVENUES Disaggregation of Revenue The Company’s products are distributed and sold principally across the U.S. and Canada through a diverse network of major retailers, including: food and drug stores, grocery stores, natural product stores, specialty outlets, and warehouse clubs; and through natural and online/e-commerce channels. The following table disaggregates the Company’s sales by channel: Three Months Ended March 31, (in thousands) 2024 2023 Retail sales $ 33,900 $ 36,927 Online/e-commerce 4,899 6,373 Net sales $ 38,799 $ 43,300 The following table disaggregates the Company’s sales by geographic location of the respective customers: Three Months Ended March 31, (in thousands) 2024 2023 U.S. $ 35,300 $ 39,347 Canada 3,499 3,953 Net sales $ 38,799 $ 43,300 Contract liabilities The Company did no t have any material unsatisfied performance obligations as of March 31, 2024 or December 31, 2023 .

Inventories

Inventories	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories	4. INVENTORIES Inventories consist of the following as of: (in thousands) March 31, 2024 December 31, 2023 Raw materials $ 2,295 $ 4,714 Finished goods 28,326 29,836 Inventories $ 30,621 $ 34,550

Property and Equipment, Net

Property and Equipment, Net	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	5. PROPERTY AND EQUIPMENT, NET Property and equipment, net, consists of the following as of: (in thousands) March 31, 2024 December 31, 2023 Leasehold improvements $ 1,167 $ 1,167 Computer equipment 703 677 Furniture and equipment 785 785 Quality control and marketing equipment 1,782 1,782 Assets not yet placed in service 101 101 4,538 4,512 Less accumulated depreciation ( 2,636 ) ( 2,403 ) Property and equipment, net $ 1,902 $ 2,109 For the three months ended March 31, 2024 and 2023, depreciation expense, including the amortization of leasehold improvements, amounted to approximately $ 0.2 million and $ 0.2 million, respectively. These amounts are included under depreciation and amortization in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss .

Intangible Assets, Net

Intangible Assets, Net	3 Months Ended
	Mar. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible Assets, Net	6. INTANGIBLE ASSETS, NET The following table provides information pertaining to the Company’s intangible assets as of: March 31, 2024 (in thousands) Weighted-Average Remaining Useful Life Gross Carrying Amount Accumulated Amortization Intangible Assets, Net Software 1.2 $ 1,164 $ ( 1,016 ) $ 148 Customer relationships 1.5 3,007 ( 2,720 ) 287 4,171 ( 3,736 ) 435 Trademarks N/A 3,000 — 3,000 Intangible assets, net $ 7,171 $ ( 3,736 ) $ 3,435 December 31, 2023 (in thousands) Weighted-Average Remaining Useful Life Gross Carrying Amount Accumulated Amortization Intangible Assets, Net Software 1.4 $ 1,164 $ ( 978 ) $ 186 Customer relationships 1.7 3,007 ( 2,670 ) 337 4,171 ( 3,648 ) 523 Trademarks N/A 3,000 — 3,000 Intangible assets, net $ 7,171 $ ( 3,648 ) $ 3,523 For the three months ended March 31, 2024 and 2023, total amortization expense amounted to $ 0.1 million and $ 0.2 million, respectively, including less than $ 0.1 million and $ 0.1 million, respectively, of amortization expense related to software. These amounts are included under depreciation and amortization in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss . No impairment losses have been recorded on any of the Company’s intangible assets for the three months ended March 31, 2024 and 2023, respectively. Amortization expense for intangible assets with definite lives is expected to be as follows: (in thousands) Remainder of 2024 258 2025 170 2026 7 Expected amortization expense for intangible assets with definite lives $ 435

Debt

Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt	7. DEBT ABL Credit Facility On February 22, 2022, Zevia LLC (the “Borrower”) obtained a revolving credit facility (the “Secured Revolving Line of Credit”) by entering into a Loan and Security Agreement with Bank of America, N.A. (the “Loan and Security Agreement”). The Borrower may draw funds under the Secured Revolving Line of Credit up to an amount not to exceed the lesser of (i) a $ 20 million revolving commitment and (ii) a borrowing base which is comprised of inventory and receivables. Up to $ 2 million of the Secured Revolving Line of Credit may be used for letter of credit issuances and the Borrower has the option to increase the commitment under the Secured Revolving Line of Credit by up to $ 10 million, subject to certain conditions. The Secured Revolving Line of Credit matures on February 22, 2027. During the first quarter of 2024, the Company drew $ 8 million on the Secured Revolving Line of Credit which was subsequently repaid in the same period. As of March 31, 2024, there was no amoun t outstanding on the Secured Revolving Line of Credit. The Secured Revolving Line of Credit is secured by a first priority security interest in substantially all of the Company’s assets. Loans under the Secured Revolving Line of Credit bear interest based on either, at the Borrower’s option, the Bloomberg Short-Term Bank Yield Index rate plus an applicable margin between 1.50 % to 2.00 % or the Base Rate (customarily defined) plus an applicable margin between 0.50 % to 1.00 % with margin, in each case, determined by the average daily availability under the Secured Revolving Line of Credit. Under the Secured Revolving Line of Credit, th e Borrower must satisfy a financial covenant requiring a minimum fixed charge coverage ratio of 1.00 to 1.00 as of the last day of any fiscal quarter following the occurrence of certain events of default that are continuing or any day on which availability under the Secured Revolving Line of Credit is less than the greater of $ 3 million and 17.5 % of the borrowing base, and must again satisfy such financial covenant as of the last day of each fiscal quarter thereafter until such time as there are no events of default and availability has been above such threshold for 30 consecutive days. As of March 31, 2024 , the Company was in compliance with its financial covenant.

Leases

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	8. LEASES The Company leases its office space which has a remaining lease term of 33 months. In January 2023, the Company entered into an amendment to the lease for its corporate headquarters offices to extend the term through December 31, 2026. The Company’s recognized lease costs include: Three Months Ended March 31, (in thousands) 2024 2023 Statements of Operations and Comprehensive Loss Operating lease cost (1) $ 184 $ 184 (1) Operating lease cost is recorded within general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss . Three Months Ended March 31, 2024 2023 Weighted-average remaining lease term (months) 33.0 45.0 Weighted-average discount rate 7.6 % 7.6 % The Company’s variable lease costs and short-term lease costs were not material. The Company is obligated under a non-cancelable lease agreement providing for office space that expires on December 31, 2026. Maturities of lease payments under the non-cancelable lease were as follows: (in thousands) March 31, 2024 2024 $ 527 2025 729 2026 756 Total lease payments 2,012 Less imputed interest ( 204 ) Present value of lease liabilities $ 1,808

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	9. COMMITMENTS AND CONTINGENCIES Purchase commitments As of March 31, 2024, the Company does not have any material agreements with suppliers for the purchase of raw material with minimum purchase quantities. Our contract manufacturers are obligated to fulfill against purchase orders that are aligned with our forecast based on terms and conditions of the contract. Our forecasts provided to our contract manufacturers are short term in nature and at no time extend beyond a year. Legal proceedings The Company is involved from time to time in various claims, proceedings, and litigation. The Company establishes reserves for specific legal proceedings when it determines that the likelihood of an unfavorable outcome is probable, and the amount of loss can be reasonably estimated. Management does not believe that the resolution of these matters would have a material impact on the accompanying unaudited condensed consolidated financial statements. The Company has not identified any legal matters where it believes a material loss is reasonably possible.

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Balance Sheet Components	10. BALANCE SHEET COMPONENTS Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following as of: (in thousands) March 31, 2024 December 31, 2023 Prepaid expenses $ 1,772 $ 1,794 Other current assets 2,193 3,269 Total $ 3,965 $ 5,063 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following as of: (in thousands) March 31, 2024 December 31, 2023 Accrued employee compensation benefits $ 1,452 $ 1,526 Accrued direct selling costs 2,544 1,113 Accrued customer paid bottle deposits 2,346 1,734 Accrued other 1,811 1,600 Total $ 8,153 $ 5,973

Equity-Based Compensation

Equity-Based Compensation	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation	11. EQUITY-BASED COMPENSATION In July 2021, prior to the IPO, the Company adopted the Zevia PBC 2021 Equity Incentive Plan (the “2021 Plan”) under which the Company may grant options, stock appreciation rights, restricted stock units (“RSUs”), restricted stock awards, other equity-based awards and incentive bonuses to employees, officers, non-employee directors and other service providers of the Company and its affiliates. The number of shares available for issuance under the 2021 Plan is increased on January 1 of each year beginning in 2022 and ending with a final increase in 2031 in an amount equal to the lesser of: (i) 5 % of the total number of shares of Class A common stock outstanding on the preceding December 31, or (ii) a smaller number of shares determined by the Company’s Board of Directors. In October and November 2021, the Company’s Board of Directors approved an amendment to its equity-based compensation plans for a certain number of employees to allow immediate vesting upon retirement of all outstanding RSUs and stock options, and to extend the exercisability of outstanding stock options up to five years after retirement, if they meet certain conditions, including a resignation after the holder has reached 50 years of age with at least 10 years of service to the Company, so long as the holder provides advance notice of his or her resignation to the Company’s Board of Directors. As of March 31, 2024, the 2021 Plan provides for future grants and/or issuances of up to approximately 2.8 million shares of our common stock. Equity-based awards under our employee compensation plans are made with newly issued shares reserved for this purpose. Stock Options The Company uses a Black-Scholes valuation model to measure stock option expense as of each respective grant date. Generally, stock option grants vest ratably over four years, have a ten-year term, and have an exercise price equal to the fair market value as of the grant date. The fair value of stock options is amortized to expense over the vesting period. The fair value of stock option awards granted during the period was determined on the grant date using the Black-Scholes valuation model based on the following weighted-average assumptions: Three Months Ended March 31, 2024 2023 Stock price $ 1.36 $ 3.00 Exercise Price 1.36 3.00 Expected term (years) (1) 6.25 6.25 Expected volatility (2) 80.3 % 62.0 % Risk-Free interest rate (3) 4.1 % 3.4 % Dividend yield (4) 0.0 % 0.0 % (1) Expected term represents the estimated period of time until an award is exercised and was determined using the simplified method. (2) Expected volatility for grants issued prior to July 21, 2023 (which is the two-year anniversary of the Company’s IPO) is based on the historical volatility of a selected peer group over a period equivalent to the expected term, and expected volatility for grants issued subsequent to July 21, 2023 is based on historical volatility of the Company’s stock. (3) The risk-free interest rate is an interpolation of yields on U.S. Treasury securities with maturities equivalent to the expected term. (4) We have assumed a dividend yield of zero as the Company has no plans to declare dividends in the foreseeable future. The weighted average grant date fair values for stock options granted for the three months ended March 31, 2024 and 2023 was $ 0.98 and $ 1.82 , respectively. The following is a summary of stock option activity for the three months ended March 31, 2024: Shares Weighted average exercise price Weighted average remaining life Intrinsic value (in thousands) Outstanding Balance as of January 1, 2024 3,080,903 $ 3.40 Granted 338,773 $ 1.36 Exercised ( 6,000 ) $ 0.03 Forfeited and expired ( 34,006 ) $ 10.17 Balance as of March 31, 2024 3,379,670 $ 3.13 7.8 $ 706 Exercisable at the end of the period 1,430,484 $ 2.73 6.3 $ 706 Vested and expected to vest 3,379,670 $ 3.13 7.8 $ 706 The total intrinsic values of stock options exercised during the three months ended March 31, 2024 was less than $ 0.1 million. As of March 31, 2024, total unrecognized compensation expense related to unvested stock options was $ 3.3 million , which is expected to be recognized over a weighted-average period of 2.7 years. Restricted Stock Units In March 2021, the Company’s Board of Directors also approved an amendment to the RSUs granted by Zevia LLC in August 2020 (“the RSU Amendment”). The RSU Amendment changed the vesting of such RSUs to occur as follows: (i) in the event of a change of control, the RSUs shall vest effective as of such change of control or (ii) in the event of an initial public offering as in the case of the IPO, the RSUs shall vest in equal monthly installments over a 36 -month period following the termination of any lockup period and shall be subject to the participant’s continued employment through such vesting date. Additionally, settlement shall occur within 30 days following the vesting of the RSUs and the participant shall be entitled to receive one share of Class A common stock for each vested RSU. All other terms remained unchanged. As a result of the RSU Amendment, the estimated fair value of the modified awards was $ 48.9 million and are being recognized as expense over the vesting period subsequent to the performance condition being met. As of March 31, 2024 , the remaining service period of the awards is 10 months . The following is a summary of RSU activity for the three months ended March 31, 2024: Shares Weighted average grant date fair value Aggregate Intrinsic Value (in thousands) Balance unvested shares at January 1, 2024 2,174,053 $ 3.68 Granted 2,398,765 $ 1.36 Vested ( 459,303 ) $ 3.75 Forfeited ( 19,905 ) $ 2.90 Balance unvested at March 31, 2024 4,093,610 $ 2.32 $ 4,790 Expected to vest at March 31, 2024 4,093,610 $ 2.32 $ 4,790 As of March 31, 2024, total unrecognized compensation expense related to unvested RSUs was $ 7.2 million, which is expected to be recognized over a weighted-average period of 3.0 years. As of March 31, 2024, there were 309,510 of RSUs outstanding which vested in 2022 but are subjected to a deferred settlement provision over the next year and therefore have not been released. As a result, these RSUs are not included in the table above.

Segment Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Segment Reporting	12. SEGMENT REPORTING The Company has one operating and reporting segment, and operates as a product portfolio with a single business platform. In reaching this conclusion, management considered the definition of the Chief Operating Decision Maker (“CODM”); how the business is defined by the CODM; the nature of the information provided to the CODM and how that information is used to make operating decisions; and how resources and performance are assessed. The Company’s CODM is the Chief Executive Officer. The results of the operations are provided to and analyzed by the CODM at the Company’s level and accordingly, key resource decisions and assessment of performance are performed at the Company’s level. The Company has a common management team across all product lines and does not manage these products as individual businesses and as a result, cash flows are not distinct.

Major Customers, Accounts Recei

Major Customers, Accounts Receivable and Vendor Concentration	3 Months Ended
	Mar. 31, 2024
Risks and Uncertainties [Abstract]
Major Customers, Accounts Receivable and Vendor Concentration	13. MAJOR CUSTOMERS, ACCOUNTS RECEIVABLE AND VENDOR CONCENTRATION The table below represents the Company’s major customers that accounted for more than 10 % of total net sales for the periods: Three Months Ended March 31, 2024 2023 Customer A 12 % 15 % Customer B * 10 % Customer C 12 % 13 % The table below represents the Company’s customers that accounted for more than 10 % of total accounts receivable, net as of: March 31, 2024 December 31, 2023 Customer B * 13 % Customer D 15 % * Customer I * 18 % The table below represents raw material and finished goods vendors that accounted for more than 10 % of all raw material and finished goods purchases for the following periods: Three Months Ended March 31, 2024 2023 Vendor A * 23 % Vendor B * 20 % Vendor C * 12 % Vendor D 42 % * Vendor E 31 % * Vendor F 20 % * The increase in vendor concentration during the three months ended March 31, 2024 was driven by the changes made in our supply chain whereby our contract manufacturers are responsible for the procurement of raw materials to produce our products, which are then sold to us as finished goods. * Less than 10 % of total net sales, accounts receivable, net or raw material and finished goods purchases in the respective periods.

Loss Per Share

Loss Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Loss Per Share	14. LOSS PER SHARE Basic loss per share of Class A common stock is computed by dividing net loss attributable to the Company for the period by the weighted-average number of shares of Class A common stock outstanding during the same period. Diluted loss per share of Class A common stock is computed by dividing net loss attributable to the Company by the weighted-average number of shares of Class A common stock outstanding adjusted to give effect to potentially dilutive securities and assumed conversion of Class B common stock into shares of Class A common stock on a one-for-one basis using the if-converted method. The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted loss per share of Class A common stock: Three Months Ended March 31, 2024 2023 (in thousands, except for share and per share amounts) Net loss per share: Numerator: Net loss and comprehensive loss $ ( 7,199 ) $ ( 2,912 ) Less: net loss attributable to non-controlling interests 1,375 821 Add: adjustment to reallocate net loss to controlling interest 70 (1) 597 (1) Net loss to Zevia PBC - basic $ ( 5,754 ) $ ( 1,494 ) Denominator: Weighted-average shares of Class A common stock outstanding – basic 55,531,430 48,336,489 Add: weighted average shares of vested and unreleased RSUs 358,738 (2) 1,036,385 (2) Weighted-average basic and diluted shares 55,890,168 49,372,874 Loss per share of Class A common stock – basic $ ( 0.10 ) $ ( 0.03 ) Diluted net loss per share: Numerator: Net loss attributable to Zevia PBC - basic $ ( 5,754 ) $ ( 1,494 ) Add: Loss attributable to noncontrolling interest upon assumed conversion — (3) ( 1,418 ) Net loss and comprehensive loss - diluted $ ( 5,754 ) $ ( 2,912 ) Denominator: Weighted-average shares of Class A common stock outstanding – basic 55,890,168 49,372,874 Dilutive effect of incremental shares for conversion of Class B units — (3) 21,631,225 Dilutive effect of stock options — (3) 844,882 Dilutive effect of restricted stock units — (3) 401,357 Weighted-average diluted shares 55,890,168 72,250,338 Loss per share of Class A common stock – diluted $ ( 0.10 ) (3) $ ( 0.04 ) (1) The numerator for the basic and diluted loss per share is adjusted for additional losses being attributed to controlling interest as a result of the impacts of vested but unreleased RSUs being included in the denominator of the basic and diluted loss per share. (2) The denominator for basic and diluted loss per share includes vested and unreleased RSUs as there are no conditions that would prevent these RSUs from being issued in the future as shares of Class A common stock except for the mere passage of time. (3) There was no assumed conversion for Class B nor diluted effect of options and RSUs for the three months ended March 31, 2024 as they were anti-dilutive. The following weighted average outstanding shares were excluded from the computation of diluted loss per share available to Class A common stockholders as they were anti-dilutive: Three Months Ended March 31, 2024 2023 Zevia LLC Class B Common Units exchangeable to shares of Class A common stock 16,239,498 — Stock options 3,127,305 1,510,563 Restricted stock units 2,582,758 1,486,597

Income Taxes And Tax Receivable

Income Taxes And Tax Receivable Agreement	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes And Tax Receivable Agreement	15. INCOME TAXES AND TAX RECEIVABLE AGREEMENT Income Taxes The Company is the managing member of Zevia LLC and as a result, consolidates the financial results of Zevia LLC in the accompanying unaudited condensed consolidated financial statements of Zevia PBC. Zevia LLC is a pass-through entity for U.S. federal and most applicable state and local income tax purposes following the Reorganization Transactions effected in connection with the IPO. As an entity classified as a partnership for tax purposes, Zevia LLC is not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by Zevia LLC is passed through to its members, including the Company. The Company is taxed as a C corporation and pays corporate federal, state and local taxes with respect to income allocated from Zevia LLC based on Zevia PBC's economic interest in Zevia LLC, which was 80.5 % and 75.8 % as of March 31, 2024 and December 31, 2023, respectively. The provision for income taxes differs from the amount of income tax computed by applying the applicable U.S. statutory federal income tax rate of 21 % to income before provision of income taxes due to Zevia LLC’s pass-through structure for U.S. income tax purposes, pass-through permanent differences, state franchise taxes, tax effects of stock-based compensation, and the valuation allowance against the deferred tax assets. Except for state franchise taxes, Zevia PBC did not recognize an income tax expense (benefit) on its share of pre-tax book loss, exclusive of the noncontrolling interest of 19.5 % , due to the full valuation allowance against its deferred tax assets (“DTAs”). Tax Receivable Agreement The Company expects to obtain an increase in its share of tax basis in the net assets of Zevia LLC when Class B units are exchanged by the holders of Class B units for shares of Class A common stock of the Company and upon certain qualifying transactions. Each change in outstanding shares of Class A common stock of the Company results in a corresponding change in the Company's ownership of Class A units of Zevia LLC. The Company intends to treat any exchanges of Class B units as direct purchases of LLC interests for U.S. federal income tax purposes. These increases in tax basis may reduce the amounts that Zevia PBC would otherwise pay in the future to various taxing authorities. They may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets. In connection with the IPO, the Company entered into a Tax Receivable Agreement (“TRA”) with continuing members of Zevia LLC and the shareholders of blocker companies (“Blocker Companies”) of certain pre-IPO institutional investors (“the Direct Zevia Stockholders” ). In the event that such parties exchange any or all of their Class B units for Class A common stock, the TRA requires the Company to make payments to such holders for 85 % of the tax benefits realized, or in some cases deemed to be realized, by the Company by such exchange as a result of (i) certain favorable tax attributes acquired from the Blocker Companies in certain mergers (including net operating losses and the Blocker Companies’ allocable share of existing tax basis), (ii) increases in tax basis resulting from Zevia PBC’s acquisition of continuing member’s Zevia LLC units in connection with the IPO and in future exchanges and, (iii) tax basis increases attributable to payments made under the TRA (including tax benefits related to imputed interest). The annual tax benefits are computed by calculating the income taxes due, including such tax benefits, and the income taxes due without such benefits. The Company expects to benefit from the remaining 15% of any tax benefits that it may actually realize. The TRA payments are not conditioned upon any continued ownership interest in Zevia LLC or the Company. To the extent that the Company is unable to timely make payments under the TRA for any reason, such payments generally will be deferred and will accrue interest until paid. The timing and amount of aggregate payments due under the TRA may vary based on a number of factors, including the amount and timing of the taxable income the Company generates each year and the tax rate then applicable. The Company calculates the liability under the TRA using a complex TRA model, which includes an assumption related to the fair market value of assets. Payments are generally due under the TRA within a specified period of time following the filing of the Company’s tax return for the taxable year with respect to which the payment obligation arises, although interest on such payments will begin to accrue at a rate of the Secured Overnight Financing Rate plus 300 basis points from the due date (without extensions) of such tax return. The TRA provides that if (i) certain mergers, asset sales, other forms of business combinations, or other changes of control were to occur; (ii) there is a material uncured breach of any obligations under the TRA; or (iii) the Company elects an early termination of the TRA, then the TRA will terminate and the Company’s obligations, or the Company’s successor’s obligations, under the TRA will accelerate and become due and payable, based on certain assumptions, including an assumption that the Company would have sufficient taxable income to fully utilize all potential future tax benefits that are subject to the TRA and that any Class B units that have not been exchanged are deemed exchanged for the fair market value of the Company’s Class A common stock at the time of termination. As of March 31, 2024, the Company believes based on applicable accounting standards, that it was more likely than not that its DTAs subject to the TRA would not be realized as of March 31, 2024 ; therefore, the Company has not recorded a liability related to the tax savings it may realize from utilization of such DTAs. The TRA liability that would be recognized if the associated tax benefits were determined to be fully realizable totaled $ 56.4 million and $ 56.2 million at March 31, 2024 and December 31, 2023, respectively. The increase in the TRA liability is primarily related to Class B to Class A exchanges during the three months ended March 31, 2024. If utilization of the DTAs subject to the TRA becomes more likely than not in the future, the Company will record a liability related to the TRA, which will be recognized as an expense within its condensed consolidated statements of operations and comprehensive loss .

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	16. SUBSEQUENT EVENTS In May 2024, we initiated certain restructuring actions designed to reduce costs and improve efficiency while continuing to invest in our brand and related initiatives. As part of the restructuring plan, the Company expects that it will restructure and reduce its current workforce and estimates that it will incur charges of approximately $ 0.5 million to $ 0.8 million of costs in the second quarter of 2024 primarily related to employee termination expenses.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Basis of Presentation	Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these financial statements do not include all information and footnotes required by U.S. GAAP for complete financial statements and are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024, or for any other interim period or any other future fiscal year. The condensed consolidated balance sheet as of December 31, 2023 included herein was derived from the audited financial statements as of that date but does not include all disclosures, including certain notes, required by U.S. GAAP that are required on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. Therefore, these interim financial statements should be read in conjunction with the financial statements for the fiscal year ended December 31, 2023 and accompanying notes included in the Annual Report. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for the fair presentation of the condensed consolidated financial statements for the periods presented have been reflected.
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiary, Zevia LLC, that it controls due to ownership of a majority equity interest. All intercompany transactions and balances have been eliminated in consolidation. The Company owns a majority economic interest in, and operates and controls all of the businesses and affairs of, Zevia LLC. Accordingly, the Company has prepared these accompanying unaudited condensed consolidated financial statements in accordance with Accounting Standards Codification (“ASC”) Topic 810, Consolidation . On January 1, 2022, the Company and Zevia LLC entered into a service agreement to transfer the services of all employees of the Company to Zevia LLC. Under terms of the service agreement between the entities, the payroll costs of employees are borne by Zevia LLC while certain other non-payroll costs, such as those associated with stock compensation arrangements, remain with the Company. In addition, pursuant to the Thirteenth Amended and Restated Limited Liability Company Agreement of Zevia LLC, dated as of July 21, 2021, Zevia LLC shall reimburse the Company for certain expenses for overhead, administrative, and other expenses, at the Company’s discretion. For the three months ended March 31, 2024 and 2023 , it was determined that the majority of such costs will be retained by the Company, with certain costs directly attributable to Zevia LLC being borne by that entity. These costs impacted the amount of net loss reported by Zevia LLC and consequently impacted the amount allocated to noncontrolling interest.
Use of estimates	Use of estimates The preparation of the accompanying unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the reported amount of net sales and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by the Company relate to: net sales and associated cost recognition; the useful lives assigned to and the recoverability of property and equipment; adjustments recorded for inventory obsolescence and adjustments made for net realizable value; the incremental borrowing rate for lease liabilities; allowance for doubtful accounts; the useful lives assigned to and the recoverability of intangible assets; realization of deferred tax assets; and the determination of the fair value of equity instruments, including restricted unit awards, and equity-based compensation awards. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of its assets and liabilities.
Recent accounting pronouncements	Recent accounting pronouncements The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the accompanying unaudited condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. Recently Issued Accounting Pronouncements – Not Yet Adopted In November 2023, the FASB issues ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . This ASU requires entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance. In December 2023, the FASB issued ASU No. 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures . The guidance requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The guidance is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The ASU is effective for private companies for annual periods beginning after December 15, 2025, with early adoption permitted. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. The Company is currently evaluating the impact of adopting this guidance. Any other recently issued accounting pronouncements are neither relevant, nor expected to have a material impact on the Company’s financial statements.

Revenues (Tables)

Revenues (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Summary of Disaggregation of Revenue	Three Months Ended March 31, (in thousands) 2024 2023 Retail sales $ 33,900 $ 36,927 Online/e-commerce 4,899 6,373 Net sales $ 38,799 $ 43,300 The following table disaggregates the Company’s sales by geographic location of the respective customers: Three Months Ended March 31, (in thousands) 2024 2023 U.S. $ 35,300 $ 39,347 Canada 3,499 3,953 Net sales $ 38,799 $ 43,300

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Summary of Inventories	Inventories consist of the following as of: (in thousands) March 31, 2024 December 31, 2023 Raw materials $ 2,295 $ 4,714 Finished goods 28,326 29,836 Inventories $ 30,621 $ 34,550

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment, Net	Property and equipment, net, consists of the following as of: (in thousands) March 31, 2024 December 31, 2023 Leasehold improvements $ 1,167 $ 1,167 Computer equipment 703 677 Furniture and equipment 785 785 Quality control and marketing equipment 1,782 1,782 Assets not yet placed in service 101 101 4,538 4,512 Less accumulated depreciation ( 2,636 ) ( 2,403 ) Property and equipment, net $ 1,902 $ 2,109

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Summary of Intangible Assets	The following table provides information pertaining to the Company’s intangible assets as of: March 31, 2024 (in thousands) Weighted-Average Remaining Useful Life Gross Carrying Amount Accumulated Amortization Intangible Assets, Net Software 1.2 $ 1,164 $ ( 1,016 ) $ 148 Customer relationships 1.5 3,007 ( 2,720 ) 287 4,171 ( 3,736 ) 435 Trademarks N/A 3,000 — 3,000 Intangible assets, net $ 7,171 $ ( 3,736 ) $ 3,435 December 31, 2023 (in thousands) Weighted-Average Remaining Useful Life Gross Carrying Amount Accumulated Amortization Intangible Assets, Net Software 1.4 $ 1,164 $ ( 978 ) $ 186 Customer relationships 1.7 3,007 ( 2,670 ) 337 4,171 ( 3,648 ) 523 Trademarks N/A 3,000 — 3,000 Intangible assets, net $ 7,171 $ ( 3,648 ) $ 3,523
Summary of Expected Amortization Expense for Intangible Assets with Definite Lives	Amortization expense for intangible assets with definite lives is expected to be as follows: (in thousands) Remainder of 2024 258 2025 170 2026 7 Expected amortization expense for intangible assets with definite lives $ 435

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Summary of Lease Cost	The Company leases its office space which has a remaining lease term of 33 months. In January 2023, the Company entered into an amendment to the lease for its corporate headquarters offices to extend the term through December 31, 2026. The Company’s recognized lease costs include: Three Months Ended March 31, (in thousands) 2024 2023 Statements of Operations and Comprehensive Loss Operating lease cost (1) $ 184 $ 184 (1) Operating lease cost is recorded within general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss . Three Months Ended March 31, 2024 2023 Weighted-average remaining lease term (months) 33.0 45.0 Weighted-average discount rate 7.6 % 7.6 %
Summary of Maturities of Lease Payments Under Non-Cancellable Leases Were As Follows	Maturities of lease payments under the non-cancelable lease were as follows: (in thousands) March 31, 2024 2024 $ 527 2025 729 2026 756 Total lease payments 2,012 Less imputed interest ( 204 ) Present value of lease liabilities $ 1,808

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following as of: (in thousands) March 31, 2024 December 31, 2023 Prepaid expenses $ 1,772 $ 1,794 Other current assets 2,193 3,269 Total $ 3,965 $ 5,063
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following as of: (in thousands) March 31, 2024 December 31, 2023 Accrued employee compensation benefits $ 1,452 $ 1,526 Accrued direct selling costs 2,544 1,113 Accrued customer paid bottle deposits 2,346 1,734 Accrued other 1,811 1,600 Total $ 8,153 $ 5,973

Equity Based Compensation (Tabl

Equity Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule for Fair Value of Stock Options Granted Estimated on the Date of Grant Using the Black-Scholes Option	Three Months Ended March 31, 2024 2023 Stock price $ 1.36 $ 3.00 Exercise Price 1.36 3.00 Expected term (years) (1) 6.25 6.25 Expected volatility (2) 80.3 % 62.0 % Risk-Free interest rate (3) 4.1 % 3.4 % Dividend yield (4) 0.0 % 0.0 % (1) Expected term represents the estimated period of time until an award is exercised and was determined using the simplified method. (2) Expected volatility for grants issued prior to July 21, 2023 (which is the two-year anniversary of the Company’s IPO) is based on the historical volatility of a selected peer group over a period equivalent to the expected term, and expected volatility for grants issued subsequent to July 21, 2023 is based on historical volatility of the Company’s stock. (3) The risk-free interest rate is an interpolation of yields on U.S. Treasury securities with maturities equivalent to the expected term. (4) We have assumed a dividend yield of zero as the Company has no plans to declare dividends in the foreseeable future.
Summary of Stock Option Activity	The following is a summary of stock option activity for the three months ended March 31, 2024: Shares Weighted average exercise price Weighted average remaining life Intrinsic value (in thousands) Outstanding Balance as of January 1, 2024 3,080,903 $ 3.40 Granted 338,773 $ 1.36 Exercised ( 6,000 ) $ 0.03 Forfeited and expired ( 34,006 ) $ 10.17 Balance as of March 31, 2024 3,379,670 $ 3.13 7.8 $ 706 Exercisable at the end of the period 1,430,484 $ 2.73 6.3 $ 706 Vested and expected to vest 3,379,670 $ 3.13 7.8 $ 706 The total intrinsic values of stock options exercised during the three months ended March 31, 2024 was less than $ 0.1 million.
Summary of Restricted Stock Unit Activity	The following is a summary of RSU activity for the three months ended March 31, 2024: Shares Weighted average grant date fair value Aggregate Intrinsic Value (in thousands) Balance unvested shares at January 1, 2024 2,174,053 $ 3.68 Granted 2,398,765 $ 1.36 Vested ( 459,303 ) $ 3.75 Forfeited ( 19,905 ) $ 2.90 Balance unvested at March 31, 2024 4,093,610 $ 2.32 $ 4,790 Expected to vest at March 31, 2024 4,093,610 $ 2.32 $ 4,790

Major Customers, Accounts Rec_2

Major Customers, Accounts Receivable and Vendor Concentration (Tables)	3 Months Ended
	Mar. 31, 2024
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]
Concentration Risk [Line Items]
Summary Sales to Significant Customers	The table below represents the Company’s major customers that accounted for more than 10 % of total net sales for the periods: Three Months Ended March 31, 2024 2023 Customer A 12 % 15 % Customer B * 10 % Customer C 12 % 13 %
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Summary Sales to Significant Customers	The table below represents the Company’s customers that accounted for more than 10 % of total accounts receivable, net as of: March 31, 2024 December 31, 2023 Customer B * 13 % Customer D 15 % * Customer I * 18 %
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member]
Concentration Risk [Line Items]
Summary Sales to Significant Customers	The table below represents raw material and finished goods vendors that accounted for more than 10 % of all raw material and finished goods purchases for the following periods: Three Months Ended March 31, 2024 2023 Vendor A * 23 % Vendor B * 20 % Vendor C * 12 % Vendor D 42 % * Vendor E 31 % * Vendor F 20 % * The increase in vendor concentration during the three months ended March 31, 2024 was driven by the changes made in our supply chain whereby our contract manufacturers are responsible for the procurement of raw materials to produce our products, which are then sold to us as finished goods. * Less than 10 % of total net sales, accounts receivable, net or raw material and finished goods purchases in the respective periods.

Loss Per Share (Tables)

Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Summary of Computation of Basic and Diluted Earnings per Share	The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted loss per share of Class A common stock: Three Months Ended March 31, 2024 2023 (in thousands, except for share and per share amounts) Net loss per share: Numerator: Net loss and comprehensive loss $ ( 7,199 ) $ ( 2,912 ) Less: net loss attributable to non-controlling interests 1,375 821 Add: adjustment to reallocate net loss to controlling interest 70 (1) 597 (1) Net loss to Zevia PBC - basic $ ( 5,754 ) $ ( 1,494 ) Denominator: Weighted-average shares of Class A common stock outstanding – basic 55,531,430 48,336,489 Add: weighted average shares of vested and unreleased RSUs 358,738 (2) 1,036,385 (2) Weighted-average basic and diluted shares 55,890,168 49,372,874 Loss per share of Class A common stock – basic $ ( 0.10 ) $ ( 0.03 ) Diluted net loss per share: Numerator: Net loss attributable to Zevia PBC - basic $ ( 5,754 ) $ ( 1,494 ) Add: Loss attributable to noncontrolling interest upon assumed conversion — (3) ( 1,418 ) Net loss and comprehensive loss - diluted $ ( 5,754 ) $ ( 2,912 ) Denominator: Weighted-average shares of Class A common stock outstanding – basic 55,890,168 49,372,874 Dilutive effect of incremental shares for conversion of Class B units — (3) 21,631,225 Dilutive effect of stock options — (3) 844,882 Dilutive effect of restricted stock units — (3) 401,357 Weighted-average diluted shares 55,890,168 72,250,338 Loss per share of Class A common stock – diluted $ ( 0.10 ) (3) $ ( 0.04 ) (1) The numerator for the basic and diluted loss per share is adjusted for additional losses being attributed to controlling interest as a result of the impacts of vested but unreleased RSUs being included in the denominator of the basic and diluted loss per share. (2) The denominator for basic and diluted loss per share includes vested and unreleased RSUs as there are no conditions that would prevent these RSUs from being issued in the future as shares of Class A common stock except for the mere passage of time. (3) There was no assumed conversion for Class B nor diluted effect of options and RSUs for the three months ended March 31, 2024 as they were anti-dilutive.
Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share	The following weighted average outstanding shares were excluded from the computation of diluted loss per share available to Class A common stockholders as they were anti-dilutive: Three Months Ended March 31, 2024 2023 Zevia LLC Class B Common Units exchangeable to shares of Class A common stock 16,239,498 — Stock options 3,127,305 1,510,563 Restricted stock units 2,582,758 1,486,597

Description of Business - Addit

Description of Business - Additional Information (Detail) - ZEVIA PBC [Member] - IPO [Member] - Common Class A [Member]	Jul. 26, 2021 $ / shares shares
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares new issues | shares	10,700,000
Sale of stock, price per share | $ / shares	$ 14

Revenues - Summary of Disaggreg

Revenues - Summary of Disaggregation of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Net sales	$ 38,799	$ 43,300
U.S. [Member]
Disaggregation of Revenue [Line Items]
Net sales	35,300	39,347
CANADA [Member]
Disaggregation of Revenue [Line Items]
Net sales	3,499	3,953
Retail sales [Member]
Disaggregation of Revenue [Line Items]
Net sales	33,900	36,927
Online/e-commerce [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 4,899	$ 6,373

Revenues - Additional Informati

Revenues - Additional Information (Detail) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation, amount	$ 0	$ 0

Inventories - Summary of Invent

Inventories - Summary of Inventories (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 2,295	$ 4,714
Finished goods	28,326	29,836
Inventories	$ 30,621	$ 34,550

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 4,538	$ 4,512
Less accumulated depreciation	(2,636)	(2,403)
Property and equipment, net	1,902	2,109
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	1,167	1,167
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	703	677
Furniture and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	785	785
Quality Control and Marketing Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	1,782	1,782
Assets not yet Placed in Service [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 101	$ 101

Property and Equipment, Net - A

Property and Equipment, Net - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 0.2	$ 0.2

Intangible Assets, Net - Summar

Intangible Assets, Net - Summary of Intangible Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Schedule Of Intangible Assets [Line Items]
Finite-Lived intangible assets, gross	$ 4,171	$ 4,171
Accumulated amortization	(3,736)	(3,648)
Finite-Lived Intangible Assets, Net, Total	435	523
Intangible assets, net	3,435	3,523
Intangible assets, net	7,171	7,171
Trademarks [Member]
Schedule Of Intangible Assets [Line Items]
Indefinite-lived intangible assets, excluding goodwill	$ 3,000	$ 3,000
Software [Member]
Schedule Of Intangible Assets [Line Items]
Weighted-Average Remaining Useful Life	1 year 2 months 12 days	1 year 4 months 24 days
Finite-Lived intangible assets, gross	$ 1,164	$ 1,164
Accumulated amortization	(1,016)	(978)
Finite-Lived Intangible Assets, Net, Total	$ 148	$ 186
Customer Relationships [Member]
Schedule Of Intangible Assets [Line Items]
Weighted-Average Remaining Useful Life	1 year 6 months	1 year 8 months 12 days
Finite-Lived intangible assets, gross	$ 3,007	$ 3,007
Accumulated amortization	(2,720)	(2,670)
Finite-Lived Intangible Assets, Net, Total	$ 287	$ 337

Intangible Assets, Net - Summ_2

Intangible Assets, Net - Summary of Expected Amortization Expense for Intangible Assets with Definite Lives (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Remainder of 2024	$ 258
2025	170
2026	7
Finite-Lived Intangible Assets, Net, Total	$ 435	$ 523

Intangible Assets, Net - Additi

Intangible Assets, Net - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule Of Intangible Assets [Line Items]
Amortization expense	$ 100,000	$ 200,000
Impairment losses on intangible assets	0	0
Software [Member]
Schedule Of Intangible Assets [Line Items]
Amortization expense	$ 100,000	$ 100,000

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended
	Feb. 22, 2022	Mar. 31, 2024	Mar. 31, 2023
Line of Credit Facility [Line Items]
Repayment of revolving line of credit		$ 8,000	$ 0
Fixed Charge Coverage Ratio	e Borrower must satisfy a financial covenant requiring a minimum fixed charge coverage ratio of 1.00 to 1.00
Loan And Security Agreement Member | Minimum [Member]
Line of Credit Facility [Line Items]
Applicable Margin	1.50%
Loan And Security Agreement Member | Maximum [Member]
Line of Credit Facility [Line Items]
Applicable Margin	2%
Secured Revolving Line of Credit [Member]
Line of Credit Facility [Line Items]
Aggregate Principal Amount	$ 20,000
Amount of line of credit use for letter of credit issuances	2,000
Commitment of secured line of credit	10,000
Repayment of revolving line of credit		8,000
Revolving line of credit facility, outstanding amount		$ 0
Borrowing base secured revolving line of credit	$ 3,000
Borrowing Base	17.50%
Secured Revolving Line of Credit [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Applicable Margin	0.50%
Secured Revolving Line of Credit [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Applicable Margin	1%

Leases - Summary of Lease Costs

Leases - Summary of Lease Costs As Follows (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Income Statement
Operating lease cost	[1]	$ 184	$ 184
Other Information
Weighted-average remaining lease term (months)		33 months	45 months
Weighted-average discount rate		7.60%	7.60%
[1] Operating lease cost is recorded within general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss .

Leases - Summary of Maturities

Leases - Summary of Maturities of Lease Payments Under Non Cancellable Leases Were As Follows (Detail) $ in Thousands	Mar. 31, 2024 USD ($)
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
2024	$ 527
2025	729
2026	756
Total lease payments	2,012
Less imputed interest	(204)
Present value of lease liabilities	$ 1,808

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid expenses	$ 1,772	$ 1,794
Other current assets	2,193	3,269
Total	$ 3,965	$ 5,063

Balance Sheet Components - Summ

Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued employee compensation benefits	$ 1,452	$ 1,526
Accrued direct selling costs	2,544	1,113
Accrued customer paid bottle deposits	2,346	1,734
Accrued other	1,811	1,600
Total	$ 8,153	$ 5,973

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining service period of the awards		10 months
Aggregate intrinsic value		$ 0.1
Equity Incentive Plan 2021 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
The amount of common stock available under the plan for future grants and/or issuances		2,800,000
Percentage of increase in shares available for issuance		5%
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated weighted average period over which expense is expected to be recognized				3 years
Share-based Payment Arrangement, Plan Modification, Incremental Cost	$ 48.9
Number of Monthly Installments Granted Equally Following The Termination Of Lockup Period	36 months
Settlement period on vesting of RSUs	30 days
Amount of cost to be recognized for non-vested award under share-based payment arrangement				$ 7.2
RSUs outstanding		4,093,610			2,174,053
Restricted Stock Units (RSUs) [Member] | 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs outstanding		309,510
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized unit compensation expense on unvested unit options		$ 3.3
Estimated weighted average period over which expense is expected to be recognized		2 years 8 months 12 days
Granted (in dollars per share)		$ 0.98	$ 1.82

Equity Based Compensation - Fai

Equity Based Compensation - Fair Value of Stock Options Granted Estimated on the Date of Grant Using the Black-Scholes Option (Details) - $ / shares		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price		$ 1.36
Exercise Price		$ 1.36
Expected term (years)	[1]	6 years 3 months
Expected volatility	[2]	80.30%
Risk-Free interest rate	[3]	4.10%
Dividend yield	[4]	0%
2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price			$ 3
Exercise Price			$ 3
Expected term (years)	[1]		6 years 3 months
Expected volatility	[2]		62%
Risk-Free interest rate	[3]		3.40%
Dividend yield	[4]		0%
[1] (1) Expected term represents the estimated period of time until an award is exercised and was determined using the simplified method. (2) Expected volatility for grants issued prior to July 21, 2023 (which is the two-year anniversary of the Company’s IPO) is based on the historical volatility of a selected peer group over a period equivalent to the expected term, and expected volatility for grants issued subsequent to July 21, 2023 is based on historical volatility of the Company’s stock. (3) The risk-free interest rate is an interpolation of yields on U.S. Treasury securities with maturities equivalent to the expected term. (4) We have assumed a dividend yield of zero as the Company has no plans to declare dividends in the foreseeable future.

Equity Based Compensation - Sum

Equity Based Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Outstanding Balance as of January 1, 2023 | shares	3,080,903
Granted | shares	338,773
Exercised | shares	(6,000)
Forfeited and expired | shares	(34,006)
Balance as of June 30, 2023 | shares	3,379,670
Exercisable at the end of the period | shares	1,430,484
Vested and expected to vest | shares	3,379,670
Weighted average exercise price, Beginning balance | $ / shares	$ 3.40
Weighted average exercise price, Granted | $ / shares	1.36
Weighted average exercise price, Exercised | $ / shares	0.03
Weighted average exercise price, Forfeited and cancelled | $ / shares	10.17
Weighted average exercise price, Ending balance | $ / shares	3.13
Weighted average exercise price, Exercisable | $ / shares	2.73
Weighted average exercise price, Vested and expected to vest | $ / shares	$ 3.13
Weighted average remaining life Outstanding	7 years 9 months 18 days
Weighted average remaining life Exercisable	6 years 3 months 18 days
Weighted average remaining life Vested and expected to vest	7 years 9 months 18 days
Aggregate intrinsic value | $	$ 706
Aggregate intrinsic value, Exercisable | $	706
Aggregate intrinsic value, Vested and expected to vest | $	$ 706

Equity Based Compensation - S_2

Equity Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member] $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Balance unvested shares at January 1, 2024 | shares	2,174,053
Restricted stock units, Granted | shares	2,398,765
Restricted stock units, Vested | shares	(459,303)
Restricted stock units, Forfeited | shares	(19,905)
Balance unvested at March 31, 2024 | shares	4,093,610
Expected to vest at March 31, 2024 | shares	4,093,610
Weighted average grant date fair value, Beginning balance | $ / shares	$ 3.68
Weighted average grant date fair value, Granted | $ / shares	1.36
Weighted average grant date fair value, Vested | $ / shares	3.75
Weighted average grant date fair value, Forfeited | $ / shares	2.9
Weighted average grant date fair value, Ending balance | $ / shares	2.32
Weighted average grant date fair value, Expected to vest at March 31, 2024 | $ / shares	$ 2.32
Aggregate intrinsic value, non vested | $	$ 4,790
Aggregate intrinsic value, Expected to vest | $	$ 4,790

Major Customers, Accounts Rec_3

Major Customers, Accounts Receivable And Vendor Concentration - Summary Sales to Significant Customers (Detail)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer A [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	12%	15%
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer B [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10%
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer C [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	12%	13%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer B [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			13%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer D [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	15%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer I [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			18%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Vendor A [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		23%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Vendor B [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		20%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Vendor C [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		12%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Vendor D [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	42%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Vendor E [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	31%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Vendor F [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%

Major Customers, Accounts Rec_4

Major Customers, Accounts Receivable And Vendor Concentration - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2024
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10%
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Customers [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customers [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Customers [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10%

Loss Per Share - Summary of Com

Loss Per Share - Summary of Computation of Basic and Diluted Earnings per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2024		Mar. 31, 2023
Basic net loss per share:
Net loss and comprehensive loss		$ (7,199)		$ (2,912)
Loss attributable to noncontrolling interest		$ 1,375		$ 821
Weighted average common units outstanding, basic		55,890,168		49,372,874
Basic earning per share		$ (0.1)		$ (0.03)
Weighted average common units outstanding, diluted		55,890,168	[1]	72,250,338
Diluted earnings per share		$ (0.1)		$ (0.04)
Common Class A [Member]
Basic net loss per share:
Net loss and comprehensive loss		$ (7,199)		$ (2,912)
Loss attributable to noncontrolling interest		1,375		821
Adjustment to reallocate net loss to controlling interest	[2]	70		597
Net Income (Loss)		$ (5,754)		$ (1,494)
Weighted average common units outstanding, basic		55,531,430		48,336,489
Basic earning per share		$ (0.1)		$ (0.03)
Loss attributable to noncontrolling interest upon assumed conversion		$ 0	[1]	$ (1,418)
Net loss and comprehensive loss - diluted		$ (5,754)		$ (2,912)
Weighted average common units outstanding, diluted		55,890,168		49,372,874
Diluted earnings per share		$ (0.1)	[1]	$ (0.04)
Common Class B [Member]
Basic net loss per share:
Dilutive effect of incremental shares		0	[1]	21,631,225
Restricted Stock Units (RSUs) [Member] | Common Class A [Member]
Basic net loss per share:
Weighted average shares of vested and unreleased RSUs	[3]	$ 358,738		$ 1,036,385
Dilutive effect of incremental shares		0	[1]	401,357
Employee Stock Option | Common Class A [Member]
Basic net loss per share:
Dilutive effect of incremental shares		0	[1]	844,882
[1] (3) There was no assumed conversion for Class B nor diluted effect of options and RSUs for the three months ended March 31, 2024 as they were anti-dilutive. (1) The numerator for the basic and diluted loss per share is adjusted for additional losses being attributed to controlling interest as a result of the impacts of vested but unreleased RSUs being included in the denominator of the basic and diluted loss per share. (2) The denominator for basic and diluted loss per share includes vested and unreleased RSUs as there are no conditions that would prevent these RSUs from being issued in the future as shares of Class A common stock except for the mere passage of time.

Loss Per Share - Summary of Ant

Loss Per Share - Summary of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Common Class A [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	16,239,498	0
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,127,305	1,510,563
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,582,758	1,486,597

Income Taxes And Tax Receivab_2

Income Taxes And Tax Receivable Agreement (Additional Information) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Income Tax Contingency [Line Items]
Federal income tax rate	21%
Income tax benefit percentage attributable to exchange for class A common stock	85%
Tax Receivable Agreement [Member]
Income Tax Contingency [Line Items]
Deferred Tax Assets Liabilities Net	$ 56.4	$ 56.2
Zevia LLC [Member]
Income Tax Contingency [Line Items]
Economic interest percentage	80.50%		75.80%
Percentage of ownership and economic interest held by non-controlling interest	19.50%

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Scenario Forecast [Member] $ in Millions	3 Months Ended
	Jun. 30, 2024 USD ($)
Minimum [Member]
Subsequent Event [Line Items]
Employee termination expenses	$ 0.5
Maximum [Member]
Subsequent Event [Line Items]
Employee termination expenses	$ 0.8